CARBOGEN AMCIS Innovations AG

Activities: Manufacturing

Visit website

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  4. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  5. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Liquid versus lyophilised: overcoming the challenges of high-potency formulations in modern pharma

Formulating highly potent (HiPo) compounds presents unique challenges that require expertise and precise decision making
Regulatory

Carbogen Amcis completes two FDA inspections at its Swiss API R&D and manufacturing facilities

The company's Neuland and Aarau sites specialise in API research and development, as well as cGMP manufacturing and analytics
Regulatory

Carbogen Amcis announces successful ANVISA audit of its facility in China

The ANVISA audit was focused on areas including utilities, maintenance and calibration, production, quality control and assurance
Regulatory

Carbogen Amcis undergoes successful Swissmedic inspection

Previous successful inspections have come in 2015, 2016, 2017 and 2020
Design & Build

Carbogen announces $110m investment in Switzerland and France

The facilities, located in Switzerland and France, will be phased in over the next four years
Manufacturing

CARBOGEN AMCIS announces successful FDA inspection

The Hunzenschwil facility is one of the company's four sites to offer development and manufacturing facilities for highly potent compounds
Media

Carbogen Amcis opens new Japanese office

The new office for the pharmaceutical process developer and API manufacturer is located in Kyoto
Subscribe now